- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
April 15, 2024Robins Kaplan Named to 2024 BTI Client Service A-Team
-
April 9, 2024Robins Kaplan LLP Files Complaint Against Social Media Giants Meta, Snap, TikTok on Behalf of Spirit Lake Nation, Menominee Indian Tribe of Wisconsin
-
April 8, 2024Tara Sutton, Emily Tremblay Shortlisted for Euromoney’s Women in Business Law Awards
-
April 24, 2024IP Leadership Executive Summit
-
April 24, 2024IP Odyssey: Navigating the Latest Developments in Intellectual Property Law
-
April 30, 2024Navigating Generational Dynamics
-
March 2024e-Commerce: Pitfalls and Protections
-
March 22, 2024‘In re Cellect’:
-
March 14, 2024How Many Cases Have You Tried to a Verdict?
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
New Drug Applications and 505(b)(2) Applications
Fourth Quarter
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA.
Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
---|---|---|---|---|
10/1/2021 | Bloxiverz | Neostigmine Methylsulfate | Exela | Indoco |
10/1/2021 | Cancidas | Caspofungin Acetate | Merck | UBI |
10/1/2021 | Mexitil | Mexiletine HCl | Boehringer-Ingelheim | Havix |
10/1/2021 | Neurontin | Gabapentin | Upjohn | Ascent Pharms |
10/1/2021 | Tamiflu | Oseltamivir Phosphate | Roche | Epic |
10/4/2021 | Emend | Fosaprepitant Dimeglumine | Merck | Praxgen |
10/4/2021 | Rhofade Cream, 1% | Oxymetazoline HCl | EPI Health | Taro |
10/5/2021 | Diovan | Valsartan | Novartis | Dr Reddy's |
10/5/2021 | Sinemet CR | Carbidopa / Levodopa | Organon | ScieGen |
10/6/2021 | Imodium | Loperamide HCl | Johnson & Johnson | Edenbridge |
10/7/2021 | Truvada | Emtricitabine / Tenofovir Disoproxil Fumarate | Gilead | Hetero |
10/7/2021 | Efudex | Fluorouracil | Bausch | Accord |
10/7/2021 | Trisenox | Arsenic Trioxide | Teva | Gland Pharma |
10/8/2021 | Cuprimine | Penicillamine | Bausch | Navinta |
10/8/2021 | Cataflam | Diclofenac Potassium | Amici | Riconpharma |
10/12/2021 | Istodax | Romidepsin | Celgene | Fresenius Kabi |
10/12/2021 | Diprivan | Propofol | Fresenius Kabi | Emcure |
10/12/2021 | Doxil | Doxorubicin HCl | Baxter Healthcare | Ayana Pharma |
10/12/2021 | Mivacron | Mivacurium Chloride | AbbVie | Woodward |
10/13/2021 | Robinul | Glycopyrrolate | Hikma | Nivagen Pharms |
10/13/2021 | Carbaglu | Carglumic Acid | Recordati | ANI |
10/14/2021 | Welchol | Colesevelam HCl | Daiichi Sankyo | Beijing Tide Pharm |
10/14/2021 | Revlimid | Lenalidomide | Celgene | Dr. Reddy's |
10/14/2021 | Cogentin | Benztropine Mesylate | Akorn | Hikma |
10/14/2021 | Tikosyn | Dofetilide | Pfizer | Granules |
10/14/2021 | Metrogel-Vaginal | Metronidazole | Bausch | Solaris |
10/14/2021 | Decadron | Dexamethasone | Merck | Amneal |
10/15/2021 | Trisenox | Arsenic Trioxide | Teva | Eugia Pharma |
10/15/2021 | Pepcid | Famotidine | Bausch | Ascent Pharms |
10/18/2021 | Zortress | Everolimus | Novartis | Par |
10/19/2021 | Questran Light | Cholestyramine Light | Bristol-Myers Squibb | Alkem Labs |
10/19/2021 | Questran | Cholestyramine | Bristol-Myers Squibb | Alkem Labs |
10/19/2021 | Zipsor | Diclofenac Potassium | Assertio | Aurobindo |
10/19/2021 | Quelicin | Succinylcholine Chloride | Hospira | Hong Kong |
10/20/2021 | Soma | Carisoprodol | Mylan | MLV |
10/20/2021 | Potassium Acetate | Potassium Acetate | Hospira | Exela Pharma |
10/20/2021 | Permitil | Fluphenazine HCl | Schering | Enaltec |
10/20/2021 | Mutamycin | Mitomycin | Bristol | Gland Pharma |
10/21/2021 | Monurol | Fosfomycin Tromethamine | Zambon | Alkem |
10/22/2021 | Imodium | Loperamide HCl | Johnson & Johnson | Bionpharma |
10/25/2021 | Inspra | Eplerenone | Upjohn | Westminster Pharms |
10/25/2021 | Mepron | Atovaquone | Glaxo | Abon |
10/25/2021 | Librax | Chlordiazepoxide HCl / Clidinium Bromide | Bausch | Amneal |
10/25/2021 | Tenoretic | Atenolol / Chlorthalidone | Almatica | ANI |
10/25/2021 | Thorazine | Chlorpromazine HCl | Glaxo | Teva |
10/27/2021 | Diovan | Valsartan | Novartis | ScieGen |
10/29/2021 | Duexis | Ibuprofen / Famotidine | Horizon | Teva |
10/29/2021 | Zebeta | Bisoprolol Fumarate | Teva | Novitium Pharma |
11/2/2021 | Librax | Chlordiazepoxide HCl / Clidinium Bromide | Horizon | Teva |
11/2/2021 | Fusilev | Levoleucovorin Calcium | Spectrum | Praxgen |
11/2/2021 | CellCept | Mycophenolate Mofetil | Roche | Amneal |
11/3/2021 | Lymphazurin | Isosulfan Blue | Mylan | Hong Kong |
11/3/2021 | Zymaxid | Gatifloxacin | AbbVie | Torrent |
11/3/2021 | Myfortic | Mycophenolic Sodium | Novartis | Twi |
11/3/2021 | Pepcid AC | Famotidine | Johnson & Johnson | Ascent Pharms |
11/4/2021 | Westcort | Hydrocortisone Valerate | Sun | Encube |
11/4/2021 | Lyrica CR | Pregabalin | Pfizer | Mylan |
11/4/2021 | Cialis | Tadalafil | Lilly | VKT Pharma |
11/4/2021 | Ziac | Bisoprolol Fumarate / Hydrochlorothiazide | Teva | Novitium Pharma |
11/4/2021 | Pepcid AC | Famotidine | Johnson & Johnson | Annora Pharma |
11/5/2021 | Focalin XR | Dexmethylphenidate HCl | Novartis | Sun |
11/8/2021 | Azactam | Aztreonam | Bristol-Myers Squibb | Pfizer |
11/8/2021 | Magnesium Sulfate | Magnesium Sulfate | Hospira | PTS Consulting |
11/8/2021 | Xylocaine | Lidocaine HCl | Fresenius Kabi | Aspiro |
11/8/2021 | Pepcid AC | Famotidine | Johnson & Johnson | Annora Pharma |
11/9/2021 | Brovana | Arformoterol Tartrate | Sunovion | Teva |
11/9/2021 | Potassium Chloride / Dextrose | Potassium Chloride / Dextrose | ICU Medical | Fresenius Kabi |
11/9/2021 | Androgel | Testosterone | AbbVie | Encube |
11/9/2021 | Robinul | Glycopyrrolate | Robins AH | Zydus |
11/10/2021 | Gilenya | Fingolimod HCl | Novartis | HEC |
11/10/2021 | Baraclude | Entecavir | Bristol-Myers Squibb | Yung Shin Pharm |
11/10/2021 | Miacalcin | Calcitonin-Salmon | Mylan | Par |
11/10/2021 | Carnitor | Levocarnitine | Leadiant | Saptalis |
11/12/2021 | Aloxi | Palonosetron HCl | Roche | Baxter |
11/12/2021 | Gilenya | Fingolimod HCl | Novartis | Teva |
11/15/2021 | Zovirax | Acyclovir | Bausch | Prinston Inc |
11/15/2021 | Lovaza | Omega-3-Acid Ethyl Esters | Glaxo | Mankind |
11/16/2021 | Bactroban | Mupirocin | Glaxo | Alembic/Aleor |
11/16/2021 | Gabitril | Tiagabine HCl | Teva | MSN |
11/16/2021 | Revatio | Sildenafil Citrate | Pfizer | Taro |
11/16/2021 | Deltasone | Prednisone | Pharmacia / Upjohn | Aurobindo |
11/17/2021 | Durezol | Difluprednate | Novartis | Amneal |
11/17/2021 | Revatio | Sildenafil Citrate | Pfizer | Tris |
11/17/2021 | Arranon | Nelarabine | Novartis | Zydus |
11/17/2021 | Nizoral | Ketoconazole | Janssen | Tasman Pharma |
11/18/2021 | Azilect | Rasagiline Mesylate | Teva | Dr. Reddy's |
11/19/2021 | Isuprel | Isoproterenol HCl | Bausch | Avet Lifesciences |
11/19/2021 | Jadenu Sprinkle | Deferasirox | Novartis | Teva |
11/19/2021 | Dacogen | Decitabine | Otsuka | Zydus |
11/22/2021 | Vibramycin | Doxycycline Hyclate | Pfizer | Nesher Pharms |
11/22/2021 | Adderall | Amphetamine / Dextroamphetamine | Teva | Accord Healthcare |
11/22/2021 | Niaspan | Niacin | AbbVie | Beijing |
11/22/2021 | Perforomist | Formoterol Fumarate | Mylan | Alembic |
11/22/2021 | Digoxin | Digoxin | Concordia | ANI / Novitium |
11/23/2021 | Focalin XR | Dexmethylphenidate HCl | Novartis | IntelliPharmaceutics |
11/23/2021 | Sprycel | Dasatinib | Bristol-Myers Squibb | Apotex |
11/23/2021 | Afinitor | Everolimus | Novartis | Hikma |
11/23/2021 | Isordil | Isosorbide Dinitrate | Bausch | Par |
11/23/2021 | Temodar | Temozolomide | Merck Sharp Dohme | Nivagen Pharms |
11/23/2021 | Cystadone | Betaine | Orphan Europe | ANI |
11/26/2021 | Zortress | Everolimus | Novartis | Alkem Labs Ltd |
11/26/2021 | Adderall XR | Amphetamine / Dextroamphetamine | Takeda | Lannett Co Inc |
11/26/2021 | Cubicin | Daptomycin | Cubist Pharms | Hangzhou Zhongmei |
11/26/2021 | Atropine Sulfate | Atropine Sulfate | Akorn | Apotex |
11/29/2021 | Myfortic | Mycophenolic Acid | Novartis | Bionpharma |
11/30/2021 | Amitiza | Lubiprostone | Takeda | Amneal |
11/30/2021 | Sutent | Sunitinib Malate | Pfizer | Teva |
12/1/2021 | Abilify | Aripiprazole | Bristol-Myers Squibb | Unichem |
12/1/2021 | Atropine Sulfate | Atropine Sulfate | Fresenius Kabi | Hikma |
12/2/2021 | Sensipar | Cinacalcet HCl | Amgen | Amneal |
12/2/2021 | Ravicti | Glycerol Phenylbutyrate | Horizon | Par |
12/2/2021 | Trisenox | Arsenic Trioxide | Teva | Sandoz |
12/3/2021 | Glucophage | Metformin HCl | EMD Serono | Harman Finochem |
12/6/2021 | Sutent | Sunitinib Malate | Pfizer | Mylan |
12/7/2021 | Uloric | Febuxostat | Takeda | Alkem |
12/8/2021 | Thioplex | Thiotepa | Amgen | Beloteca |
12/8/2021 | Lamictal XR | Lamotrigine | Glaxo | Yiling |
12/8/2021 | Focalin XR | Dexmethylphenidate HCl | Novartis | Hetero |
12/9/2021 | NuvaRing | Ethinyl Estradiol / Etonogestrel | Merck | Dr. Reddy's |
12/13/2021 | Timoptic in Ocudose | Timolol Maleate | Bausch | IndentiRx |
12/13/2021 | Glumetza | Metformin HCl | Bausch | Apotex |
12/13/2021 | Advair Diskus | Fluticasone Propionate / Salmeterol Xinafoate | Glaxo | Teva |
12/14/2021 | AmBiosone | Amphotericin B | Astellas | Sun |
12/15/2021 | Vasostrict | Vasopressin | Endo / Par | Eagle |
12/17/2021 | Bystolic | Nebivolol HCl | AbbVie | Cadila Pharms |
12/17/2021 | Bystolic | Nebivolol HCl | AbbVie | Aurobindo |
12/17/2021 | Bystolic | Nebivolol HCl | AbbVie | Reyoung |
12/17/2021 | Mycobutin | Rifabutin | Pfizer | ANI |
12/21/2021 | Periactin | Cyproheptadine HCl | Merck | Tris Pharma |
12/21/2021 | Tecfidera | Dimethyl Fumarate | Biogen | Sawai |
12/22/2021 | Depacon | Valproate Sodium | AbbVie | Mylan |
12/22/2021 | Atripla | Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate | Gilead | Laurus |
12/23/2021 | Renagel | Sevelamer Carbonate | Genzyme | Lupin |
12/23/2021 | Minipress | Prazosin HCl | Pfizer | Granules |
12/27/2021 | Cerdelga | Eliglustat Tartrate | Genzyme | Teva |
12/27/2021 | Rapamune | Sirolimus | Pfizer | Torrent |
12/28/2021 | AccuNeb | Albuterol Sulfate | Mylan | RiteDose |
12/28/2021 | Adderall | Amphetamine / Dextroamphetamine | Teva | Granules |
12/30/2021 | Corlanor | Ivabradine HCl | Amgen | Centaur Pharms |
GENERICally Speaking Hatch Waxman Bulletin
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
Fourth Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
December 29, 2023
Corcept Therapeutics, Inc. v. Teva Pharms. USA, Inc.
GENERICally Speaking Hatch Waxman Bulletin
December 13, 2023
Acadia Pharms. Inc. v. Aurobindo Pharma Ltd.
GENERICally Speaking Hatch Waxman Bulletin
December 7, 2023
H. Lundbeck A/S v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
November 7, 2023
Eisai R&D Mgmt. Co., Ltd. v. Dr Reddy’s Labs., Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.